Assessing iPSC reprogramming methods for their suitability in translational medicine.

Journal of Cellular Biochemistry
Mahendra S Rao, Nasir Malik

Abstract

The discovery of the ability to induce somatic cells to a pluripotent state through the overexpression of specific transcription factors has the potential to transform the ways in which pharmaceutical agents and cellular transplantation therapies are developed. Proper utilization of the technology to generate induced pluripotent stem cells (iPSCs) requires that researchers select the appropriate reprogramming method for generating iPSCs so that the resulting iPSCs can be transitioned towards clinical applications effectively. This article reviews all of the currently available reprogramming techniques with a focus on critiquing them on the basis of their utility in translational medicine.

References

Jun 9, 2004·Developmental Biology·Mi-Ra SuhKye-Seong Kim
Nov 22, 2007·Science·Junying YuJames A Thomson
Aug 20, 2008·Molecular and Cellular Biology·Deborah A Greer CardTrevor K Archer
Sep 27, 2008·Science·Matthias StadtfeldKonrad Hochedlinger
Dec 20, 2008·Stem Cells·Cesar A SommerGustavo Mostoslavsky
Apr 14, 2009·Nature Biotechnology·Robert L JudsonRobert Blelloch
Apr 29, 2009·Cell Stem Cell·Hongyan ZhouSheng Ding
Jun 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Eirini P PapapetrouMichel Sadelain
Sep 1, 2009·Cell Stem Cell·Yoshinori YoshidaShinya Yamanaka
Oct 3, 2009·Cell Stem Cell·Alexandra HaaseUlrich Martin
Oct 20, 2009·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Noemi FusakiMamoru Hasegawa
Oct 20, 2009·Nature Methods·Tongxiang LinSheng Ding
Feb 9, 2010·Nature Methods·Fangjun JiaJoseph C Wu
Jul 14, 2010·Cell Stem Cell·Judith StaerkRudolf Jaenisch
Feb 3, 2011·The EMBO Journal·Zhonghan LiTariq M Rana
Apr 5, 2011·Nature Methods·Keisuke OkitaShinya Yamanaka
Apr 9, 2011·Cell Stem Cell·Frederick Anokye-DansoEdward E Morrisey
Apr 12, 2011·Nature Methods·Guokai ChenJames A Thomson
May 31, 2011·Cell Stem Cell·Norikatsu MiyoshiMasaki Mori
Aug 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi BanShin-Ichi Nishikawa

❮ Previous
Next ❯

Citations

Jul 19, 2012·Journal of Cardiovascular Translational Research·Pieterjan DierickxLinda W van Laake
Jun 10, 2015·The American Journal of Pathology·Chandan K Sen, Subhadip Ghatak
Oct 6, 2015·The American Journal of Pathology·Chandan K Sen
Sep 24, 2015·Nature Reviews. Drug Discovery·Erin A Kimbrel, Robert Lanza
Sep 1, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Magdalena LaugschKonstantinos Anastassiadis
Apr 19, 2015·Biochemical and Biophysical Research Communications·Na Rae HanSeung Tae Lee
Apr 14, 2016·International Journal of Molecular Sciences·Vanessa M Doulames, Giles W Plant
May 14, 2016·Experimental Neurology·M Joana Osorio, Steven A Goldman
Jul 5, 2016·European Journal of Pharmacology·Frans SchutgensMaarten B Rookmaaker
Sep 16, 2016·Journal of Cellular Physiology·James KehlerAntonio Giordano
Oct 10, 2014·Stem Cells Translational Medicine·Robert BarrettDhruv Sareen
Sep 11, 2013·Journal of Biomolecular Screening·Anastasia EfthymiouNasir Malik
Nov 11, 2015·Expert Reviews in Molecular Medicine·Gary Hin-Fai YamJodhbir S Mehta
Feb 2, 2017·Cell Biology and Toxicology·Britta J H DriessenLucienne A Vonk
Nov 5, 2015·Current Opinion in Organ Transplantation·Mathew G Angelos, Dan S Kaufman
Jan 19, 2018·Stem Cells and Development·Donghui LiuHong Liao
Apr 11, 2019·Cellular Reprogramming·Laura TarnawskiStefan Jovinge
Sep 25, 2019·Stem Cell Research & Therapy·Nimshitha Pavathuparambil Abdul ManaphChristopher John Drogemuller
Nov 23, 2019·World Journal of Cardiology·Nerea Jimenez-Tellez, Steven C Greenway
Jun 7, 2017·Stem Cell Research & Therapy·Christopher E SchmittAnn C Zovein
Jul 14, 2017·Molecular Autism·Jamie ReillySanbing Shen
Jul 21, 2017·NPJ Parkinson's Disease·Staffan HolmqvistLaurent Roybon
Jun 1, 2018·Current Protocols in Molecular Biology·Arun SharmaChristine E Seidman
Oct 29, 2020·Scientific Reports·Javier Frontiñan-RubioEster Vázquez
May 15, 2021·Cell & Bioscience·Tianyuan Shi, Martin Cheung
Jun 22, 2021·Frontiers in Bioengineering and Biotechnology·Mira ChingaleKe Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.